News & Events
News & Events
[2019 Pasteur Colloquium] Dr. Najet Srairi-Abid, Institut Pasteur Tunis
2019-07-01
___________________________________________
IPK Pasteur Colloquium
Date : Jul. 04 (Thu.), 2019 at 11:00am
Venue : Monod Room (1F), Institut Pasteur Korea
_______________________________________________________________________________________________________
SPEAKER
Najet Srairi-Abid, Ph.D.
Leader, Venoms and Therapeutic Biomolecules Laboratory, Institut Pasteur Tunis
TALK TITLE
Animal venom biomolecules: Tools for oncogenesis study and targeted therapy against cancers
* For more information, please contact at sukyon.yang@ip-korea.org or visit our website: www.ip-korea.org.
** Directions to IPK: http://www.ip-korea.org/about_us/location.php
IPK Pasteur Colloquium
Date : Jul. 04 (Thu.), 2019 at 11:00am
Venue : Monod Room (1F), Institut Pasteur Korea
_______________________________________________________________________________________________________
SPEAKER
Najet Srairi-Abid, Ph.D.
Leader, Venoms and Therapeutic Biomolecules Laboratory, Institut Pasteur Tunis
TALK TITLE
Animal venom biomolecules: Tools for oncogenesis study and targeted therapy against cancers
ABSTRACT
The anticancer activities of scorpion and snakes venoms have been reported, both in vitro and in vivo. We showed that these venoms are rich in analog molecules of various compounds that already displayed effect against different cancer cell lines. Some peptides are yet purified and characterized in the laboratory of venoms and therapeutic biomolecules. Of the known molecules including KAaH1, KAaH2, H9, H8 and P01 from Androctonus autralis Hector have shown inhibiting activity on the hallmarks of U87, LS174 or MDA-MB- 231 cancer cells. Today’s presentation will focus on some of these biological effects and promising uses of the venom.
___________________________________________
The anticancer activities of scorpion and snakes venoms have been reported, both in vitro and in vivo. We showed that these venoms are rich in analog molecules of various compounds that already displayed effect against different cancer cell lines. Some peptides are yet purified and characterized in the laboratory of venoms and therapeutic biomolecules. Of the known molecules including KAaH1, KAaH2, H9, H8 and P01 from Androctonus autralis Hector have shown inhibiting activity on the hallmarks of U87, LS174 or MDA-MB- 231 cancer cells. Today’s presentation will focus on some of these biological effects and promising uses of the venom.
___________________________________________
* For more information, please contact at sukyon.yang@ip-korea.org or visit our website: www.ip-korea.org.
** Directions to IPK: http://www.ip-korea.org/about_us/location.php